Company Profile

Arbor Rapha Capital Bioholdings Corp. I is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The Company has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination. The Company intend to focus on technologies with the healthcare to improve the lives of patients. The Company has not commenced any operations nor generated any revenue.

Employees

Sector

Investment Holding Companies

More about the company

23/01/23	Arbor Rapha Capital Bioholdings Corp. I(NasdaqGM:ARCK) dropped from NASDAQ Composite Index	CI
05/01/23	Top Premarket Gainers	MT
11/11/22	Arbor Rapha Capital Bioholdings Corp. I Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
11/08/22	Arbor Rapha Capital Bioholdings Corp. I Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI
13/05/22	Arbor Rapha Capital Bioholdings Corp. I Reports Earnings Results for the First Quarter Ended March 31, 2022	CI
26/04/22	Certain Class B Common Stock of Arbor Rapha Capital Bioholdings Corp. I are subject to a Lock-Up Agreement Ending on 26-APR-2022.	CI
29/03/22	Arbor Rapha Capital Bioholdings Corp. I Reports Earnings Results for the Ten Months Ended December 31, 2021	CI
29/03/22	Arbor Rapha Capital Bioholdings Corp. I Auditor Raises 'Going Concern' Doubt	CI
21/12/21	Arbor Rapha Capital Bioholdings Corp. I(NasdaqGM:ARCK) added to NASDAQ Composite Index	CI
28/10/21	Arbor Rapha Capital Bioholdings Corp. I has completed an IPO in the amount of $150 million.	CI
14/09/21	Arbor Rapha Capital Bioholdings Corp. I has filed an IPO in the amount of $150 million.	CI

19/01/23	Arbor Rapha Capital Bioholdings I : Announces NASDAQ Delisting - Form 8-K	PU
19/01/23	ARBOR RAPHA CAPITAL BIOHOLDINGS CORP. I : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
13/01/23	Nasdaq Halts Arbor Rapha Capital Bioholdings Corp. I	AQ
10/12/22	ARBOR RAPHA CAPITAL BIOHOLDINGS CORP. I : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
11/11/22	ARBOR RAPHA CAPITAL BIOHOLDINGS CORP. I Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ

Manager	Title	Age	Since
Ivan Kaufman CEO	Chief Executive Officer	65	-
Paul Elenio DFI	Director of Finance/CFO	58	-
Kevin Slawin PRN	Corporate Officer/Principal	65	-

Director	Title	Age	Since
Ivan Kaufman CHM	Chairman	65	-
Kevin Slawin BRD	Director/Board Member	65	-
Ralph Mack BRD	Director/Board Member	66	01/11/2021

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ARBOR RAPHA CAPITAL BIOHOLDINGS CORP. I	-13.27%	-16.20%	-	-	257M
EINRIDE AB	+17.31%	-9.42%	-	-	1.07B
CENTIEL AG	-9.46%	-6.81%	+379.35%	-61.51%	773M
CHURCHILL CAPITAL CORP XI	+11.41%	+34.50%	-	-	772M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	-0.20%	-0.50%	-	-	640M
BAIN CAPITAL GSS INVESTMENT CORP.	-0.10%	+0.59%	-	-	600M
CANTOR EQUITY PARTNERS IV, INC.	-0.15%	-0.25%	-	-	592M
CHURCHILL CAPITAL CORP XII	+0.48%	+3.88%	-	-	586M
KEYSTONE ACQUISITION CORP.	-0.10%	0.00%	-	-	580M
Average	+0.66%	+2.75%	+379.35%	-61.51%	701.39M
Weighted average by Cap.	+2.81%	+2.40%	+379.35%	-61.51%

Arbor Rapha Capital Bioholdings Corp. I Stock

Stocks

ARCK

US03881F1049

Investment Holding Companies

Latest news : Arbor Rapha Capital Bioholdings Corp. I

Press Releases: Arbor Rapha Capital Bioholdings Corp. I

Quotes and Performance

Managers and Directors: Arbor Rapha Capital Bioholdings Corp. I

Shell Companies

Company Profile